Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 37

1.

Late Plasma Cell Depletion After Thymoglobulin Induction in Kidney Transplant Recipients.

Irure J, Sango C, Segundo DS, Fernández-Fresnedo G, Ruiz JC, Benito-Hernández A, Asensio E, López-Hoyos M, Rodrigo E.

Exp Clin Transplant. 2019 Apr 9. doi: 10.6002/ect.2018.0261. [Epub ahead of print]

2.

Regulatory T-cell Number in Peripheral Blood at 1 Year Posttransplant as Predictor of Long-term Kidney Graft Survival.

San Segundo D, Galván-Espinoza LH, Rodrigo E, Irure J, Ruiz JC, Fernández-Fresnedo G, Riesco L, Bada J, Belmar L, Lopez-Hoyos M.

Transplant Direct. 2019 Feb 8;5(3):e426. doi: 10.1097/TXD.0000000000000871. eCollection 2019 Mar.

3.

A proliferation-inducing ligand increase precedes IgA nephropathy recurrence in kidney transplant recipients.

Martín-Penagos L, Benito-Hernández A, San Segundo D, Sango C, Azueta A, Gómez-Román J, Fernández-Fresnedo G, López-Hoyos M, Ruiz JC, Rodrigo E.

Clin Transplant. 2019 Apr;33(4):e13502. doi: 10.1111/ctr.13502. Epub 2019 Mar 11.

PMID:
30776158
4.

Data on a new biomarker for kidney transplant recipients: The number of FoxP3 regulatory T cells in the circulation.

Herrera-Gómez F, Del Aguila W, Tejero-Pedregosa A, Adler M, Padilla-Berdugo R, Maurtua-Briseño-Meiggs Á, Pascual J, Pascual M, San Segundo D, Heidt S, Álvarez FJ, Ochoa-Sangrador C, Lambert C.

Data Brief. 2018 Nov 27;21:2567-2575. doi: 10.1016/j.dib.2018.11.083. eCollection 2018 Dec.

5.

Anti-perlecan antibodies and acute humoral rejection in hypersensitized patients without forbidden HLA specificities after kidney transplantation.

Riesco L, Irure J, Rodrigo E, Guiral S, Ruiz JC, Gómez J, López-Hoyos M, San Segundo D.

Transpl Immunol. 2019 Feb;52:53-56. doi: 10.1016/j.trim.2018.11.002. Epub 2018 Nov 17.

PMID:
30458294
6.

Multi-centre validation of a flow cytometry method to identify optimal responders to interferon-beta in multiple sclerosis.

Villarrubia N, Rodríguez-Martín E, Alari-Pahissa E, Aragón L, Castillo-Triviño T, Eixarch H, Ferrer JM, Martínez-Rodríguez JE, Massot M, Pinto-Medel MJ, Prada Á, Rodríguez-Acevedo B, Urbaneja P, Gascón-Gimenez F, Herrera G, Hernández-Clares R, Salgado MG, Oterino A, San Segundo D, Cuello JP, Gil-Herrera J, Cámara C, Gómez-Gutiérrez M, Martínez-Hernández E, Meca-Lallana V, Moga E, Muñoz-Calleja C, Querol L, Presas-Rodríguez S, Teniente-Serra A, Vlagea A, Muriel A, Roldán E, Villar LM.

Clin Chim Acta. 2019 Jan;488:135-142. doi: 10.1016/j.cca.2018.11.008. Epub 2018 Nov 5.

PMID:
30408481
7.

The number of FoxP3 regulatory T cells in the circulation may be a predictive biomarker for kidney transplant recipients: A multistage systematic review.

Herrera-Gómez F, Del Aguila W, Tejero-Pedregosa A, Adler M, Padilla-Berdugo R, Maurtua-Briseño-Meiggs Á, Pascual J, Pascual M, San Segundo D, Heidt S, Álvarez FJ, Ochoa-Sangrador C, Lambert C.

Int Immunopharmacol. 2018 Dec;65:483-492. doi: 10.1016/j.intimp.2018.10.028. Epub 2018 Nov 1.

PMID:
30390595
8.

NFκB activation in differentiating glioblastoma stem-like cells is promoted by hyaluronic acid signaling through TLR4.

Ferrandez E, Gutierrez O, Segundo DS, Fernandez-Luna JL.

Sci Rep. 2018 Apr 20;8(1):6341. doi: 10.1038/s41598-018-24444-6.

9.

Human neutrophils phagocytose and kill Acinetobacter baumannii and A. pittii.

Lázaro-Díez M, Chapartegui-González I, Redondo-Salvo S, Leigh C, Merino D, Segundo DS, Navas J, Icardo JM, Acosta F, Ocampo-Sosa A, Martínez-Martínez L, Ramos-Vivas J.

Sci Rep. 2017 Jul 4;7(1):4571. doi: 10.1038/s41598-017-04870-8.

10.

Assessment of Spanish Panel Reactive Antibody Calculator and Potential Usefulness.

Asensio E, López-Hoyos M, Romón Í, Ontañón J, San Segundo D.

Front Immunol. 2017 May 11;8:540. doi: 10.3389/fimmu.2017.00540. eCollection 2017.

11.

Intermediate steroid withdrawal after renal transplantation and anti-HLA antibodies (HLA-Abs) development.

Monfá E, San Segundo D, San Millán JCR, Sanabria J, Albines Z, Rodrigo E, Romón I, Asensio E, Arias M, López-Hoyos M.

Nefrologia. 2017 Jul - Aug;37(4):415-422. doi: 10.1016/j.nefro.2017.02.002. Epub 2017 Mar 19. English, Spanish.

12.

Improvement in the definition of anti-HLA antibody profile in highly sensitized patients.

Irure J, Asensio E, Rodrigo E, Romón Í, Gómez J, Arias M, López-Hoyos M, San Segundo D.

PLoS One. 2017 Feb 3;12(2):e0171463. doi: 10.1371/journal.pone.0171463. eCollection 2017.

13.

Implementation of a National Priority Allocation System for Hypersensitized Patients in Spain, Based on Virtual Crossmatch: Initial Results.

Valentin MO, Ruiz JC, Vega R, Martín C, Matesanz R; working group PATHI.

Transplant Proc. 2016 Nov;48(9):2871-2875. doi: 10.1016/j.transproceed.2016.09.024.

PMID:
27932095
14.

Increased Expression Profile and Functionality of TLR6 in Peripheral Blood Mononuclear Cells and Hepatocytes of Morbidly Obese Patients with Non-Alcoholic Fatty Liver Disease.

Arias-Loste MT, Iruzubieta P, Puente Á, Ramos D, Santa Cruz C, Estébanez Á, Llerena S, Alonso-Martín C, San Segundo D, Álvarez L, López Useros A, Fábrega E, López-Hoyos M, Crespo J.

Int J Mol Sci. 2016 Nov 10;17(11). pii: E1878.

15.

Within-Patient Variability in Tacrolimus Blood Levels Predicts Kidney Graft Loss and Donor-Specific Antibody Development.

Rodrigo E, Segundo DS, Fernández-Fresnedo G, López-Hoyos M, Benito A, Ruiz JC, de Cos MA, Arias M.

Transplantation. 2016 Nov;100(11):2479-2485.

PMID:
26703349
16.

Regulatory T Cells as Biomarkers for Rejection and Immunosuppression Tailoring in Solid Organ Transplantation.

López-Hoyos M, San Segundo D, Brunet M.

Ther Drug Monit. 2016 Apr;38 Suppl 1:S36-42. doi: 10.1097/FTD.0000000000000265. Review.

PMID:
26977998
17.

Different in vitro proliferation and cytokine-production inhibition of memory T-cell subsets after calcineurin and mammalian target of rapamycin inhibitors treatment.

Merino D, San Segundo D, Medina JM, Rodrigo E, Asensio E, Irure J, Fernández-Fresnedo G, Arias MA, López-Hoyos M.

Immunology. 2016 Jun;148(2):206-15. doi: 10.1111/imm.12603. Epub 2016 Mar 29.

18.

High expression of CD38, CD69, CD95 and CD154 biomarkers in cultured peripheral T lymphocytes correlates with an increased risk of acute rejection in liver allograft recipients.

Boix F, Millan O, San Segundo D, Mancebo E, Rimola A, Fabrega E, Fortuna V, Mrowiec A, Castro-Panete MJ, Peña Jde L, Llorente S, Minguela A, Bolarin JM, Paz-Artal E, Lopez-Hoyos M, Brunet M, Muro M.

Immunobiology. 2016 May;221(5):595-603. doi: 10.1016/j.imbio.2016.01.008. Epub 2016 Jan 25.

PMID:
26850323
19.

High proportion of CD95(+) and CD38(+) in cultured CD8(+) T cells predicts acute rejection and infection, respectively, in kidney recipients.

Mancebo E, Castro MJ, Allende LM, Talayero P, Brunet M, Millán O, Guirado L, López-Hoyos M, San Segundo D, Rodrigo E, Muñoz P, Boix Giner F, Llorente Viñas S, Muro-Amador M, Paz-Artal E.

Transpl Immunol. 2016 Feb;34:33-41. doi: 10.1016/j.trim.2016.01.001. Epub 2016 Jan 7.

PMID:
26773856
20.

Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation.

Cuadrado A, San Segundo D, López-Hoyos M, Crespo J, Fábrega E.

World J Gastroenterol. 2015 Oct 21;21(39):11016-26. doi: 10.3748/wjg.v21.i39.11016. Review.

Supplemental Content

Loading ...
Support Center